======= VPS8 ======= == Gene Information == * **Official Symbol**: VPS8 * **Official Name**: VPS8 subunit of CORVET complex * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23355|23355]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N3P4|Q8N3P4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VPS8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VPS8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618366|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in vesicle-mediated protein trafficking of the endocytic membrane transport pathway. Believed to act as a component of the putative CORVET endosomal tethering complexes which is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations (PubMed:25266290). Functions predominantly in APPL1-containing endosomes (PubMed:25266290). {ECO:0000269|PubMed:25266290, ECO:0000305|PubMed:25266290}. |Vps8| |CORVET complex| |endosomal vesicle fusion| |vesicle fusion| |organelle membrane fusion| |organelle fusion| |membrane fusion| |early endosome| |vesicle organization| |membrane organization| |protein transport| |peptide transport| |amide transport| |establishment of protein localization| |nitrogen compound transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.26| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.71| |[[:results:exp280|Daidzin 10μM R06 exp280]]|1.76| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.76| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|1.96| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.18| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.19| ^Gene^Correlation^ |[[:human genes:t:tgfbrap1|TGFBRAP1]]|0.476| |[[:human genes:a:ap2s1|AP2S1]]|0.455| |[[:human genes:v:vps45|VPS45]]|0.447| |[[:human genes:r:rab5c|RAB5C]]|0.427| |[[:human genes:c:cyb561a3|CYB561A3]]|0.402| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1967 * **Expression level (log2 read counts)**: 5.34 {{:chemogenomics:nalm6 dist.png?nolink |}}